title: Primary intestinal B-cell lymphoma: a prospective multicentre clinical study of 91 cases.
abstract: OBJECTIVE
  Clinical presentation, diagnosis and prognosis of different primary intestinal lymphomas have not been well described and compared so far. Our aim was to prospectively analyse a series of consecutive patients presenting different types of B-cell primary intestinal lymphomas.
  
  
  METHODS
  Adult patients with primary intestinal lymphoma, collected between 1991 and 2000 within the multicenter national study in France were evaluated and followed up prospectively. Clinical features and treatment outcomes were analyzed and compared among different groups of lymphomas.
  
  
  RESULTS
  Among 91 cases of B-cell primary intestinal lymphomas identified, 38 (41%) were diffuse large B cell lymphomas, 34 (37%) mantle cell lymphomas, 12 (13%) follicular lymphomas, 5 (5%) marginal zone MALT-lymphomas, and 2 (3%) Burkitt's lymphomas. A differential diagnosis could be made on the basis of tumour cell morphology and phenotype assessed by immunohistochemistry. Clinical presentation of the different types of lymphomas varied with respect to age, symptoms, circumstances of diagnosis, and stage. Overall survival was the poorest for mantle cell lymphomas while diffuse large B cell lymphomas could be cured if in complete remission after first line treatment.
  
  
  CONCLUSIONS
  This study underlines the existence, within the B-cell primary intestinal lymphomas, of several distinct entities with different clinico-pathological features and prognosis, whose identification is important for choosing appropriate therapeutic strategy.
authors.affiliation: Institute of Digestive Diseases (IMAD) and Department of Gastroenterology, Hotel Dieu Hospital, Nantes. Electronic address: tamara.matysiakbudnik@chu-nantes.fr.
authors.forename: Tamara
authors.initials: T
authors.lastname: Matysiak-Budnik
authors.forename: Philippe
authors.initials: P
authors.lastname: Jamet
authors.forename: Bettina
authors.initials: B
authors.lastname: Fabiani
authors.forename: Isabelle
authors.initials: I
authors.lastname: Nion-Larmurier
authors.forename: Zora
authors.initials: Z
authors.lastname: Marjanovic
authors.forename: Agnes
authors.initials: A
authors.lastname: Ruskoné-Fourmestraux
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D005602:France / Q000453:epidemiology; D006801:Humans; D007150:Immunohistochemistry; D007414:Intestinal Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D016393:Lymphoma, B-Cell / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D011446:Prospective Studies; D015996:Survival Rate / Q000639:trends; D016896:Treatment Outcome; D055815:Young Adult
keywords: B-cell lymphoma; DLBCL; Follicular lymphoma; MALT lymphoma; Mantle cell lymphoma; Primary intestinal lymphoma; Prospective study